In vivo studies have shown that RBC polyamine levels can be ation and in cancer development. Ninety percent of the circulatused as an index of neoplastic 10 and normal cell prolifering spermidine (Spd) and spermine (Spm) are transported by ation. 11 We have shown that RBC Spd levels can be used as populations with a significantly different outcome.
common ALL in the Department of Pediatric Hematology at the University Hospital in Rennes. All patients were included in French trials ongoing at the moment of the diagnosis Introduction including (1) induction phase with vincristin, prednisone, anthracycline, l-asparaginase; (2) consolidation phase with Common acute lymphoblastic leukemias (ALL) in children are high dose methotrexate; (3) CNS-directed therapy with intrausually classified according to their clinical and biological thecal therapy and cerebral irradiation; and (4) continuation status at the time of diagnosis. For 20 years, age, liver and phase with daily administration of 6-mercaptopurine and spleen size, and white blood cell (WBC) count have been the weekly administration of methotrexate. 13 major parameters in use to classify standard or high risk leukemias; 1 these factors were also used as the basis for the choice of treatment. As treatment progressively improved survival Diagnosis rates reached 75% of EFS probability, 2 and some prognostic factors have disappeared. Today, the major negative prognostic criteria is a WBC count higher than 200 × 10 3 /l. 2, 3 In Acute lymphoblastic leukemia was established when at least addition to clinical and biological factors at diagnosis, the 25% lymphoblasts were present in the bone marrow. Comresponse to chemotherapy became an important factor for the mon ALL was defined by immunophenotyping with positive evaluation of prognosis. 2 Response to treatment depends on expression of CD10 and CD19 and negative expression of surthe biological status of ALL cells 4 and on the biological status face Ig (sIg) and of myeloid or T antigens. According to the of patients, more than on leukemic mass or patient age. 5 clinical and biological classification, we recorded at the diagIntracellular polyamine metabolism is closely associated nosis: age, size of the spleen, liver and adenopathies, hemowith the cell cycle and ornithine decarboxylase is a key globin level and WBC count. Splenomegaly and hepatomeenzyme of polyamine biosynthesis. 6 Ornithine decarboxylase galy were considered positive if they reached umbilic level. and polyamines have been implicated to play a role in cell Adenopathies were considered as positive if the number was proliferation and in cancer development. 7 The positive above 2. charges of spermine results in it binding strongly to DNA and stabilizes certain conformations of DNA and RNA. 8 These changes may have important consequences for DNA-protein Determination of RBC polyamine levels or DNA-drug interactions in the cell. Ninety percent of the circulating Spd and spermine Spm are transported by RBC. 9 RBC Spd and Spm levels were prospectively determined at diagnosis before RBC transfusion. The method of polyamine extraction from red blood cells and determination by high class, preserves the notion of distribution around the median
and attenuates the dichotomous effect of class boundaries.
Furthermore, from the multiple correspondence analysis
results, values serve as cut-off points to separate patients in
order to test survival or the prognostic value of the chosen variable. 17 The clinical symptoms were coded as being for categorized variables. The correlations were established by Spearman correlation. The Kaplan-Meier method was used to estimate survival rates between groups and differences were The Spm and Spd levels were not correlated with WBC count (r = 0.29) but Spm was correlated with Spd (r = 0.83). compared by log-rank test with Mentel's method. [18] [19] [20] EFS and RFS were calculated from the first day of treatment to the time Splenomegaly and WBC counts were dependent ( 2 = 11.2 and P Ͻ 0.002) but Spm and splenomegaly were not depenof analysis or to the first event (failure to achieve complete remission; relapse or toxic death for EFS, relapse for RFS). We dent ( 2 = 3.27, P, not significant). The multiple correspondence analysis revealed significant compared our method with Cox regression analysis 21 as published by Nakache et al. The multiple correspondence analylinks between clinical and biological parameters before treatment, and the ascending hierarchical classification has stratisis and the ascending hierarchical classification were performed with the LOGINSERM 1979/1987 software (Institut fied our patients into four homogeneous subpopulations C1, C2, C3 and C4. Discriminative parameters for this classiNational de la Santé et de la Recherche Médicale, Paris, France) and survival analysis, Cox regression with BMDP prg fication were biological parameters. Based on polyamine levels four groups were discriminated (P Ͻ 10 −3 ). Based on WBC 1L and 2L (University of California, Berkeley, CA, USA).
counts only group C1 could be distinguished from other groups (P Ͻ 10 −3 ), and group C3 from C4 (P Ͻ 0.05). Age, splenomegaly, hepatomegaly, adenopathy, hemoglobin were Results not discriminative to separate these four groups. Polyamine levels and white blood cell counts according to each group All 63 children had common ALL according to the FAB classification and immunological criteria (CD10 + , CD19 + and surare shown in Table 2 . The outcome of patients belonging to these subgroups was face Ig − ). The median age was 5 (range 0.8 to 15) years for the 27 boys and 36 girls. The median WBC at diagnosis was different. From five patients with toxic death before CR, one was in group C1, three were in C2 and one was in C3. The 12 000/l (range 1000 to 810 000). The clinical and biologic features used for the analysis are shown in Table 1 . Five early calculated RFS probability of the 58 children in CR was 55% ± 9 with a follow-up of 50 months (4-180). For the C1, death were observed during the induction phase, three patients died in first CR by toxicity. Nineteen patients C2, C3 and C4 groups, the RFS was 25% ± 20 (n = 6), 73% ± 12 (n = 16), 73% ± 13 (n = 21) and 32% ± 13 (n = 15) relapsed, six of them are still alive in second CR. The probability of EFS of 63 patients was 48% ± 7, and the probability respectively. The Mantel-Cox test discriminated whole groups with P Ͻ 0.003. The difference between C3 and C4 was sigof overall survival without disease in first or second CR was 60% ± 7. The median follow-up was 44 months (range 1-nificant with P Ͻ 0.048 (Table 2) .
The most informative cut-off value for RBC Spm concen-180).
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Table 2
Characteristics of the subgroups of ALL patients revealed by hierachical ascending classification analysis Subgroups C1 C4 C3 C2 n = 7 n = 15 n = 22 n =19 Differences between all groups were significant (P Ͻ 0.003). Differences between C3 and C4 was significant with a P Ͻ 0.048.
tration as obtained from multicorrespondence analyses was Ͻ13 nmol/8 × 10 9 RBC; their EFS was 54% ± 11. Twenty out of 63 had Spm levels у13; their EFS was 33% ± 10. This dif-13 nmol/8 × 10 9 RBC. The calculated RFS probability of children according to Spm levels were significantly different ference was significant at P Ͻ 0.03. The calculated overall survival probability of children without disease in first or (P Ͻ 0.005) if patients with an Spm level Ͻ13 or у13 nmol/8 × 10 9 RBC were compared ( Figure 1 ). Based on second CR was 81% ± 5 for the 43 children with RBC Spm Ͻ13 and 33% ± 10 for the 20 patients with RBC Spm у13. WBC counts, the differences of RFS were not significant (Table 3 ). The sensitivity, specificity and the relative risk indiThis difference is highly significant (P Ͻ 0.002) (Figure 2 ). Six patients out of 19 relapsed late (median delay time = 43 cated by Spm levels were high (respectively 85%, 82% and 11.6). Sensitivity, specificity and the relative risk of some months against 26 months for the whole group) and are still alive with a median follow-up of 66 months (24-119). Four others classic clinical and biological parameters are shown in Table 4 .
patients received bone marrow transplantation with a followup of 47, 74, 94 and 119 months respectively, one patient Forty-three out of 63 children had an Spm levels 9 RBC (38% ± 11). Difference between the two groups was significant (P Ͻ 0.005).
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Table 3
Relapse-free survival probability of the 58 patients risk factor' (risk ratio = 1.7 and P Ͻ 0. (11) are correlated, but the power of discrimination of Spm is always more important than Spd one. On the other hand the NS, not significant; s.e., standard error.
specificity of Spm is 82% vs 60% for Spd (data not shown).
We considered the 58 patients in CR to evaluate the probability of Based on the RBC spermine level at diagnosis it was possible RFS and calculated the differences of probability of RFS by the Mantel-Cox test.
to discriminate, subgroups of patients (C3 and C4). These groups could not be distinguished by other clinical or biological factors. Groups C3 and C4 were characterized by moder- 
RBC) as
The sensitivity is the proportion of relapsed patients with Spm у13
an indicator of relapse were also very high (85% and 82%, in whole relapsed patients. The specificity is the proportion of no respectively) with regard to WBC count and other characterrelapse patients with Spm Ͻ13 in whole no relapse patients. Relaistics. Since we did not find any correlation between RBC Spm tive risk is the factor which increases the risk of relapse depending level and WBC count, RBC Spm level seems to be an indeon variable.
pendent biologic parameter without linkage to the leukemic cell mass. The differences in Spm accumulation in RBC in cases of was treated with high-dose chemotherapy and autologous bone marrow rescue with a follow-up of 24 months; one leukemia with good or poor prognosis is not understood. Spm is normally not released by cells, unless cells lose viability. patient received chemotherapy alone with a follow-up of 58 months. The median RBC Spm level of these six patients was Enhancement of Spm concentrations in RBC could be the sign of an important quantity of leukemia cell death before any seven (range 1-10).
A Cox stepwise regression analysis with WBC count, treatment. One may speculate that spontaneous death (apoptosis) of leukemia cells is correlated with a good Spm у13, adenopathy, splenomegaly and hepatomegaly demonstrated that Spm у13 nmol/8 × 10 9 RBC is a significant response to treatment. As has been shown by our group, RBC polyamines reflect polyamine metabolism in tumour cells. 25 predictive factor for poor outcome (Table 5) . But in this case, a high RBC Spm level would be correlated with a good response and prognosis contrary to our results. In the case of leukemia, another hypothesis could be disDiscussion cussed. The increase of RBC polyamine levels could reflect an increase of leukemia cell polyamine levels according to WBC counts over 200 × 10 3 l or age below 1 year define a high risk early pre-B ALL in children regardless of the treatdifferences in polyamine metabolism of the leukemia cells. A decrease in polyamine oxydase activity enhancing leukemia ment. 3 The best features at the time of diagnosis to predict a favorable outcome in common ALL are age between 1 and 9 cell Spm level may be assumed based on a previous experimental report. 26 Spermine stabilizes chromatin and certain years and leukocyte counts lower than 50 × 10 3 /l. 22 Between these two clinical features, the parameters suitable to decide enzymes because of its ability to associate with organic polyanions such as negatively charged groups of proteins and the intensity or the modification of the treatment are still under discussion. Blood blast counts together with the size of spleen DNA. 27 Polyamine-depleted cells are more sensitive to antitumor agents which bind to DNA. 28 Spm prevents endonucleand liver gave an arbitrary margin for the separation of standard and high risk ALL patients. 23 The dependence between ase activation and apoptosis in rat thymocytes in a concentration-dependent fashion. 29 This capacity of Spm efficiency spleen size and WBC counts is well known and may explain that WBC counts у20 × 10 3 /l is a more influential parameter to block DNA fragmentation was related to its interaction with endonucleases or their substrate, DNA, and was related to its (risk ratio = 2.06 and P Ͻ 0.0001) than the 'leukemic cell mass Kaplan-Meier estimate of overall survival without disease and event-free survival according to RBC Spm level for 63 children. (---) Overall survival without disease of patients with Spm Ͻ13 (81% ± 6); (....) event-free survival of patients with Spm Ͻ13 (54% ± 11); (---) overall survival without disease of patients with Spm у13 (30% ± 10), (---) event-free survival of patients with Spm у13 (33% ± 10); overall survival Spm Ͻ13 vs Spm у13 (P Ͻ0.002); EFS Spm Ͻ13 vs Spm у13 (P Ͻ 0.03).
Table 5
Multivariate analysis on RFS by Cox stepwise regression
In conclusion, our clinical study shows that RBC Spm levels test can be considered as a parameter of prognosis at the time of diagnosis particularly for patients with intermediary WBC 
